The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute Migraine
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark Pierce, MD
NuPathe Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
34 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Little Rock, Arkansas, United States
- Facility name not stated
Newport Beach, California, United States
- Facility name not stated
San Francisco, California, United States
- Facility name not stated
Santa Monica, California, United States
- Facility name not stated
Fairfield, Connecticut, United States
- Facility name not stated
Ocala, Florida, United States
- Facility name not stated
Palm Beach Gardens, Florida, United States
- Facility name not stated
Sunrise, Florida, United States
- Facility name not stated
Atlanta, Georgia, United States
- Facility name not stated
Columbus, Georgia, United States
- Facility name not stated
Decatur, Georgia, United States
- Facility name not stated
Savannah, Georgia, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Ann Arbor, Michigan, United States
- Facility name not stated
Kalamazoo, Michigan, United States
- Facility name not stated
Springfield, Missouri, United States
- Facility name not stated
St Louis, Missouri, United States
- Facility name not stated
Mount Vernon, New York, United States
- Facility name not stated
Plainview, New York, United States
- Facility name not stated
Greensboro, North Carolina, United States
- Facility name not stated
West Chester, Ohio, United States
- Facility name not stated
Oklahoma City, Oklahoma, United States
- Facility name not stated
Philadelphia, Pennsylvania, United States
- Facility name not stated
Pittsburgh, Pennsylvania, United States
- Facility name not stated
Wynnewood, Pennsylvania, United States
- Facility name not stated
Memphis, Tennessee, United States
- Facility name not stated
Nashville, Tennessee, United States
- Facility name not stated
Dallas, Texas, United States
- Facility name not stated
Houston, Texas, United States
- Facility name not stated
San Antonio, Texas, United States
- Facility name not stated
Alexandria, Virginia, United States
- Facility name not stated
Virginia Beach, Virginia, United States
- Facility name not stated
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jan 2009
- Primary completion
- 31 Jul 2009
- Completion
- 31 Jul 2009
- Last update posted
- 4 Feb 2016
- Registered enrollment
- 530
- Registry id
- NCT00724815
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.